Drug firm Abbott India today posted an increase of 72.63% in its net profit at Rs 29.52 crore for the second
quarter ended June 30, 2012.
The company had posted a net profit of Rs 17.10 crore during the same period of previous year, Abbott India said in a filing to the BSE.
Net sales of the company rose to Rs 402.83 crore for the first quarter ended June 30, 2012 as compared to Rs 351.50 crore during the same
period of previous year.
In 2010, Abbott had acquired India's Piramal Healthcare's domestic formulation business for USD 3.72 billion (about Rs 17,484 crore), thereby
making it one of the largest drug firms in the country.
Shares of Abbott India today closed at Rs 1,508.75 on the BSE, up 0.40% from its previous close.
